6E10 alkaline phosphatase immunohistochemical detection of Aβ/APP in FFPE brain sections
This protocol uses the mouse monoclonal antibody 6E10 for alkaline-phosphatase immunohistochemistry on 2–3 µm FFPE brain sections, including dewaxing and rehydration, heat antigen retrieval in citrate buffer, formic acid treatment, hydrogen peroxide and normal goat serum blocking, overnight primary antibody incubation, alkaline-phosphatase secondary antibody incubation, FastBlue development and hematoxylin counterstaining. 6E10 recognizes beta-amyloid epitopes including APP, so the signal is not equivalent to insoluble plaque alone and does not give absolute Aβ40/Aβ42 concentrations. The validated source material is FFPE human brain; application to mouse brain expressing human or humanized Aβ requires endogenous-IgG and negative controls, and that boundary must remain in interpretation. The AD APPswe/PS1dE9 immunohistochemistry scope includes 174 studies; among commonly used reagents absent from the BOM, anti-GFAP and anti-APP antibodies were each used in 3 studies.
Scope and method
Sample:2–3 µm FFPE brain tissue sections. The sample validated in this source version is FFPE human brain tissue; use in mouse brain tissue expressing human or humanized Aβ is an extended application based on the target and workflow.
Bill of materials (BOM)
| Step | Material | Role | Amount | Required / optional | SKU / specification |
|---|---|---|---|---|---|
| Alkaline phosphatase-conjugated secondary antibody incubation | Goat Anti-Mouse IgG Alkaline Phosphatase Conjugated Secondary Antibody (Jackson 115-055-003) | Alkaline phosphatase-conjugated secondary antibody · Jackson ImmunoResearch catalog number 115-055-003; goat anti-mouse IgG; alkaline phosphatase conjugated; on mouse tissue it can bind endogenous mouse IgG | Dilute 1:100, 2 h at room temperature | Required | Available for inquiry |
| Primary antibody incubation | 6E10 Anti-Human β-Amyloid Mouse Monoclonal Antibody (Zytomed Z 932002-Y) | Primary antibody, recognizes human β-amyloid/APP epitope · Zytomed Systems GmbH Catalog No. Z 932002-Y; Clone 6E10; Mouse host; Target human β-amyloid; 6E10 recognizes APP and Aβ fragments | Dilute 1:500, incubate overnight at room temperature | Required | Available for inquiry |
| Normal goat serum blocking | Normal goat serum (normal goat serum) | Non-specific binding blocking · Normal goat serum, prepared as a 10% working solution in TBS by volume | Prepare as a 10% working solution in TBS, 10 min at room temperature | Required | Available for inquiry |
| Hydrogen peroxide blocking | 3% Hydrogen Peroxide/TBS Working Solution (for Immunohistochemistry Blocking) | Endogenous peroxidase blocking · 3% hydrogen peroxide working solution in TBS; treat at room temperature for 10 min (the source protocol only specifies this working solution concentration and treatment time) | Prepare as a 3% working solution in TBS, 10 min at room temperature | Required | Available for inquiry |
| Formic acid treatment | Formic acid (formic acid, 98%) | Aβ epitope exposure · Formic acid, 98%; source protocol for β-amyloid immunohistochemistry | 98% formic acid, room temperature, 1 min | Required | Available for inquiry |
| TBS washing | Tris-buffered saline (TBS, pH 7.5) | Washing and working solution preparation buffer · Tris-buffered saline solution, pH 7.5; not a single compound | 3 times for each washing step; used to prepare 3% hydrogen peroxide, 10% normal goat serum, and primary antibody diluent | Required | Available for inquiry |
| Heat-induced retrieval in citrate buffer | Citric acid-sodium citrate antigen retrieval buffer (10 mM, pH 6) | Heat-induced antigen retrieval buffer · 10 mM citric acid-sodium citrate buffer system, pH 6; source protocol for heat-induced antigen retrieval | 1× 10 mM, pH 6; steam treatment for 30 min | Required | Available for inquiry |
| Distilled water washing | Distilled water (aqua dest, for histological staining) | Hydration washing · Distilled water (aqua dest), used for hydration and washing in histological staining; not a single-formulation product | Wash 3 times with distilled water | Required | Available for inquiry |
| Isopropanol:xylene transition | Isopropanol | Rehydration gradient solvent · Isopropanol, CAS 67-63-0; PubChem CID 3776; prepare a gradient according to the nominal concentration | Steps 5–9: isopropanol:xylene 1:1, 100%, 90%, 70%, 50% isopropanol, respectively 1 or 2 times, 3 min each | Required | Available for inquiry |
| Aquatex mounting | Aquatex Aqueous Mounting Medium | Aqueous mounting · Aquatex aqueous mounting medium; commercial formulation | Mount with an appropriate amount of mounting medium. | Required | Available for inquiry |
| Hematoxylin counterstaining | Hematoxylin staining solution | Nuclear counterstaining · Hematoxylin staining solution, for counterstaining nuclei in tissue sections | Counterstain for 10 s | Required | Available for inquiry |
| FastBlue color development | FastBlue Alkaline Phosphatase Chromogenic Working Solution (contains Naphtol AS Mix Phosphat, Levamisol, FastBlue) | Alkaline phosphatase substrate chromogenic · Prepare and filter according to the source protocol before use; multi-component color development system | 49 mL TBS pH 7.5, 1 mL Naphtol AS Mix Phosphate, 50 µL Levamisole, 25 mg FastBlue; color development 30–60 min | Required | Available for inquiry |
| Xylene deparaffinization | Histological xylene (mixed isomers) | Dewaxing and Clearing Solvents · Histological grade xylene mixed isomers; Fisherbrand HistoPrep catalog number HC7001GAL, the manufacturer identifies this mixture with CAS 1330-20-7 | Step 4: xylene 4 times, 5 min each; Step 5: treat once with a 1:1 mixture with isopropanol, 3 min | Required | Available for inquiry |
Inquire about the whole BOM
Bulk pricing and availability inquiry
Submitting an inquiry does not place an order or confirm a purchase.
Procedure
Paraffin section preparation
Perform immunohistochemical staining on 2–3 µm thick paraffin sections.
Removal of excess paraffin
Remove excess paraffin at 56° for 1h–24h.
Rehydration
Rehydrate.
Xylene deparaffinization
Treat with xylene 4 times for 5 min each.
Isopropanol:xylene transition
Treat once with isopropanol:xylene 1:1 for 3 min.
100% isopropanol
Treat twice with 100% isopropanol for 3 min each.
90% isopropanol
Treat once with 90% isopropanol for 3 min.
70% isopropanol
Treat once with 70% isopropanol for 3 min.
50% isopropanol
Treat once with 50% isopropanol for 3 min.
Distilled water washing
Wash 3 times with distilled water.
Antigen retrieval
Perform antigen retrieval.
Heat-induced retrieval in citrate buffer
Perform heat-induced retrieval in 1× citrate buffer (10 mM, pH 6) using steam for 30 min.
TBS washing
Wash 3 times with TBS.
Formic acid treatment
Treat with 98% formic acid at room temperature for 1 min for β-amyloid immunohistochemistry.
TBS washing
Wash 3 times with TBS.
Hydrogen peroxide blocking
Treat with TBS containing 3% hydrogen peroxide at room temperature for 10 min.
TBS washing
Wash 3 times with TBS.
Normal goat serum blocking
Block with TBS containing 10% normal goat serum at room temperature for 10 min.
Decant blocking solution
Decant the TBS containing 10% normal goat serum without washing and proceed directly to the next step.
Primary antibody incubation
Incubate with the primary antibody in TBS containing 10% normal goat serum overnight at room temperature in a humidified chamber. The primary antibody is 6E10 (Zytomed Systems GmbH, catalog number Z 932002-Y), targeting human β-amyloid, with a mouse host, diluted 1:500.
TBS washing
Wash 3 times with TBS.
Alkaline phosphatase-conjugated secondary antibody incubation
Incubate with the alkaline phosphatase-conjugated secondary antibody diluted 1:100 for 2 h at room temperature in a humidified chamber. The secondary antibody is Jackson ImmunoResearch 115-055-003, goat anti-mouse IgG.
TBS washing
Wash 3 times with TBS.
FastBlue color development
Develop with FastBlue for 30–60 min: combine 49 mL TBS (pH 7.5), 1 mL Naphtol AS Mix Phosphat, 50 µL Levamisol, and 25 mg FastBlue, mix well, and filter.
TBS washing
Wash 3 times with TBS.
Hematoxylin counterstaining
Counterstain with hematoxylin for 10 s.
Running water rinse
Rinse with tap water for 10 min.
Aquatex mounting
Mount with Aquatex.
Quality control and readouts
Include a positive control known to contain human Aβ and a negative control omitting the primary antibody in each staining batch. For mouse brain tissue, also include a primary-antibody-omission control or a mouse IgG isotype control to assess background from the anti-mouse secondary antibody and endogenous IgG. Interpret staining in the target region only when the positive control shows blue deposits at the expected location and the negative and endogenous IgG controls lack the corresponding signal.
Observe blue deposits formed by the FastBlue alkaline phosphatase substrate in the target brain region, with a distribution consistent with 6E10-reactive human or humanized Aβ/APP epitopes; interpret together with positive, negative, and endogenous IgG controls. This protocol does not independently distinguish Aβ40 from Aβ42 and does not directly equate staining intensity with insoluble plaque burden or absolute concentration. Quantification requires a separately established image acquisition and analysis procedure.
References
- Jonas Franz, Katja Schulz, Christine Stadelmann. Immunhistochemistry (Stadelmann Lab - single antibody, AP). protocols.io, v1, 2025-09-11. DOI: 10.17504/protocols.io.3byl4952rgo5/v1 · DOI: 10.17504/protocols.io.3byl4952rgo5/v1
- Sturchler-Pierrat et al. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. DOI:10.1073/pnas.94.24.13287; PMID:9371838. · DOI: 10.1073/pnas.94.24.13287
- Johnson-Wood et al. 1997. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. DOI:10.1073/pnas.94.4.1550; PMID:9037091. · DOI: 10.1073/pnas.94.4.1550
- RIKEN. 2014-04-14. New mouse model could revolutionize research in Alzheimer’s disease. Original laboratory figure for Saito et al., Nature Neuroscience 2014, DOI:10.1038/nn.3697. · DOI: 10.1038/nn.3697